Bambusa Therapeutics Competitors: 10 Similar Biotech

Bambusa Therapeutics — investors and similar companies (57)

Companies comparable to Bambusa Therapeutics in Biotech, headquartered in Boston, United States, ranked by how much of Bambusa Therapeutics's verified investor base they share. 150 of the companies below have at least one backer in common with Bambusa Therapeutics.

Overlap is computed from disclosed round records rather than from sector labels, so a company appears here because the same firms wrote cheques into both — the signal a founder benchmarking comparables or an investor mapping a sector actually wants. Each entry links to that company's own funding record and syndicate breakdown.

• Verified backers on record: 9
• Total disclosed funding: $105M
• Latest tracked round: Series A (2025-02-14)
• Sector: Biotech
• Headquarters: Boston, United States

• RA Capital Management
• Janus Henderson Investors
• Redmile Group
• Invus
• ADAR1 Capital Management
• BVF Partners L.P.
• Dawn Biopharma
• Salvia GmbH
• INCE Capital
• Endeavor BioMedicines — shares Invus
• Nucleix — shares RA Capital Management
• Black Diamond Therapeutics — shares BVF Partners L.P. +3
• ProfoundBio — shares Janus Henderson Investors +1
• Point Biopharma — shares RA Capital Management
• TScan Therapeutics — shares RA Capital Management
• Enliven Therapeutics — shares Janus Henderson Investors
• Neumora Therapeutics — shares Invus
• Apogee Therapeutics — shares RA Capital Management
• Neuron23 — shares Redmile Group
• Talaris Therapeutics — shares Invus
• Tyra Biosciences — shares Janus Henderson Investors
• ADARx Pharmaceuticals — shares Invus +1
• Metagenomi — shares RA Capital Management
• Adcytherix — shares Dawn Biopharma +1
• Kinnate Biopharma — shares Janus Henderson Investors
• Diagonal Therapeutics — shares RA Capital Management +1
• Moderna Therapeutics — shares Invus +1
• cAMPfield Therapeutics — shares RA Capital Management
• Ray Therapeutics — shares Janus Henderson Investors +1
• Parabilis Medicines — shares RA Capital Management +1
• Design Therapeutics — shares Janus Henderson Investors +1
• Asher Bio — shares RA Capital Management +1
• Alentis Therapeutics — shares RA Capital Management
• Gritstone Oncology — shares Redmile Group
• Xeris Pharmaceuticals — shares Redmile Group
• LifeMine Therapeutics — shares Invus
• Imbria Pharmaceuticals — shares RA Capital Management
• Connect Biopharmaceuticals — shares RA Capital Management
• Boundless Bio — shares RA Capital Management +1
• Saluda Medical — shares Redmile Group
• LEXEO Therapeutics — shares Janus Henderson Investors
• Alterome Therapeutics — shares Invus
• Gracell Biotechnologies — shares RA Capital Management +1
• BlossomHill Therapeutics — shares Janus Henderson Investors
• ILiAD Biotechnologies — shares RA Capital Management +1
• Angitia Biopharmaceuticals — shares Janus Henderson Investors +1
• ShouTi — shares BVF Partners L.P. +1
• Windward Bio — shares RA Capital Management +1
• Sironax — shares Invus
• Zentalis Pharmaceuticals — shares Redmile Group
• New Amsterdam Pharma — shares BVF Partners L.P. +1
• NiKang Therapeutics — shares RA Capital Management +2
• Earendil Labs — shares INCE Capital
• Artios Pharma — shares Invus
• Lycia Therapeutics — shares Janus Henderson Investors +2
• IQM Quantum Computers — shares Salvia GmbH
• Korsana Biosciences — shares Janus Henderson Investors

Bambusa Therapeutics funding profile · All research reports